Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effectiveness, Safety and Tolerability of LevoCept (Levonorgestrel-Releasing Intrauterine System) for Long-Acting Reversible Contraception

NCT02882191 is registered in ClinicalTrials.gov with Sebela Women's Health Inc. as lead sponsor.

NCT NCT02882191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02882191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effectiveness, Safety and Tolerability of LevoCept (Levonorgestrel-Releasing Intrauterine System) for Long-Acting Reversible Contraception
Lead sponsor
Sebela Women's Health Inc.
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2016
Completion date
November 12, 2020
Enrollment
279 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

contraception